Results from an early-stage study of Loxo Oncology Inc.'s targeted cancer therapy keep getting better, the company said at the American Society of Clinical Oncology meeting taking place this weekend in Chicago.
from Bloomberg https://ift.tt/2Jm5pjL
Subscribe to:
Post Comments (Atom)
-
Caroline Purser/Getty Images The S&P 500 has shed 4% since the beginning of the year as Big Tech stocks decline. However, previou...
-
The Bell V-280 Valor was selected as the Army's future long-range assault aircraft in 2022. Photo courtesy of Bell The US Army desi...
-
Anna Kim/Getty, Yana Iskayeva/Getty, bob_bosewell/Getty, Morsa Images/Getty, Antonio Garcia Recena/Getty, Morsa Images/Getty, Anna Moneym...
No comments:
Post a Comment